Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in CRSP — CRISPR Therapeutics AG

CIK 1452765 NEW YORK, NY

Position in CRSP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$370,427
-$970,880 QoQ
Shares Held
7,787
-62.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Sep 30, 2024
CallValue
$751,680
CallShares
16,000
PutValue
$2,785,914
PutShares
59,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GTS SECURITIES LLC holds $7,337,364 across 30 Biotechnology names. CRSP ranks #5 (5.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 CRSP
CRISPR Therapeutics AG
This page
7,787 $370,427

All Filings in CRSP

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $370,427 7,787
2025-09-30 $1,341,307 20,696
2024-09-30 $2,785,914 59,300
2024-09-30 $751,680 16,000
2024-09-30 $2,424,496 51,607
2024-06-30 $4,034,547 74,700
2024-06-30 $2,225,806 41,211
2024-06-30 $2,538,470 47,000
2024-03-31 $4,498,560 66,000
2024-03-31 $1,313,920 19,277
2024-03-31 $4,444,032 65,200
2023-12-31 $3,511,860 56,100
2023-12-31 $6,679,420 106,700
2023-12-31 $4,342,687 69,372
2023-09-30 $2,201,415 48,500
2023-09-30 $2,909,499 64,100
2023-09-30 $1,883,957 41,506
2023-06-30 $1,549,351 27,598